中信證券(06030.HK):截至目前中信集團未討論過任何關於中信證券及中信建投重組合並的方案
格隆匯 7 月 5日丨中信證券(06030.HK)公佈,有關針對媒體報道公司將與中信建投合並事項的澄清。公司於2020年7月3日收到上交所《關於中信證券股份有限公司有關媒體報導事項的監管工作函》,要求公司對上述媒體報導所涉事項做進一步説明。公司於2020年7月3日向第一大股東中國中信有限公司("中信有限")書面徵詢上述媒體報導所涉事項,並於2020年7月4日收到中信有限書面回覆:"經與中信集團確認,截至目前中信集團未討論過任何關於中信證券及中信建投重組合並的方案,中信集團也未與中央匯金投資有限責任公司簽署涉及收購中信建投股票的任何協議"。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.